Head to head

GentleMax Pro vs Splendor X (2026)

The biggest practical difference is cost of entry: GentleMax Pro's new pricing is $70.0k, while Splendor X's is $130k–$165k. They are used for different treatments (GentleMax Pro: dual-wavelength platform; Splendor X: dual-wavelength laser), so the right pick depends on which treatments you're building demand for.

Category group: Hair removal (diode, alexandrite, Nd:YAG, IPL)

Device A

Device B

Price comparison

Price comparison: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
New price range	$70.0k	$130k–$165k
Used asking range	$29.0k-$67k (core cluster $37.7k-$57.5k)	$70k–$110k
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Candela GentleMax Pro: $70.0k
Lumenis Splendor X: $130k–$165k

Used asking range

Candela GentleMax Pro: $29.0k-$67k (core cluster $37.7k-$57.5k)
Lumenis Splendor X: $70k–$110k

Payback calculator

Candela GentleMax Pro: View ROI calculator
Lumenis Splendor X: View ROI calculator

Next step

Candela GentleMax Pro

Lumenis Splendor X

Consumable economics

Consumable economics: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
Consumable cost / lock-in	Not consumable-free — the DCD cryogen is a true per-treatment consumable, the exception in its category. Not published — Candela does not publish US cryogen, distance-gauge or flashlamp list pricing, and cryogen consumption per treatment is not published by any source, so no per-treatment figure is published here.	No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.
Service cost	Not published	Not published

Consumable cost / lock-in

Candela GentleMax Pro: Not consumable-free — the DCD cryogen is a true per-treatment consumable, the exception in its category. Not published — Candela does not publish US cryogen, distance-gauge or flashlamp list pricing, and cryogen consumption per treatment is not published by any source, so no per-treatment figure is published here.
Lumenis Splendor X: No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.

Service cost

Candela GentleMax Pro: Not published
Lumenis Splendor X: Not published

FDA clearance

FDA clearance: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
FDA status & indication	FDA ClearedK140122, K201111 “The GentleMAX Family of Laser Systems is indicated for the following at the specified wavelength: 7S5nm Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction isdefined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick [- VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as pant-wine stains, hemangiomas, telangiectasias) 1064nm Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction isdefined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au ]ait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. 1064nm Temporary increase of clear nail in patients with onychomycosis (e.g., derniatophytes, Trichophyton rubrum and T. mentagrophytes, and for yeast Candida Albicans, etc.)”	FDA ClearedK241407, K243445 “The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”

FDA status & indication

Candela GentleMax Pro: FDA ClearedK140122, K201111
“The GentleMAX Family of Laser Systems is indicated for the following at the specified wavelength: 7S5nm Temporary hair reduction. Stable long-term or permanent reduction through selective targeting of melanin in hair follicles. Permanent hair reduction isdefined as long-term stable reduction in the number of hairs regrowing after a treatment regime. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types (Fitzpatrick [- VI) including tanned skin. Treatment of benign pigmented lesions. Treatment of wrinkles. The photocoagulation of dermatological vascular lesions (such as pant-wine stains, hemangiomas, telangiectasias) 1064nm Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of PFB. Permanent hair reduction isdefined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types Fitzpatrick I-VI including tanned skin. Photocoagulation and hemostasis of pigmented and vascular lesions such as but not limited to port wine stains, hemangioma, warts, telangiectasia, rosacea, venus lake, leg veins and spider veins. Coagulation and hemostasis of soft tissue. Benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sun spots), cafd au ]ait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. Treatment of wrinkles. 1064nm Temporary increase of clear nail in patients with onychomycosis (e.g., derniatophytes, Trichophyton rubrum and T. mentagrophytes, and for yeast Candida Albicans, etc.)”
Lumenis Splendor X: FDA ClearedK241407, K243445
“The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”

Which chains run each

Which chains run each: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
Chain adoption	3 recorded pairings	0 recorded pairings
Chains using it	Milan Laser Hair Removal(Confirmed) SEV Laser(Confirmed) Body Details(Confirmed)	—
Approved reviews	0	0

Chain adoption

Candela GentleMax Pro: 3 recorded pairings
Lumenis Splendor X: 0 recorded pairings

Chains using it

Candela GentleMax Pro: Milan Laser Hair Removal(Confirmed)
SEV Laser(Confirmed)
Body Details(Confirmed)
Lumenis Splendor X: —

Approved reviews

Candela GentleMax Pro: 0
Lumenis Splendor X: 0

Specs and platform

Specs and platform: Candela GentleMax Pro vs Lumenis Splendor X
Attribute	Candela GentleMax Pro	Lumenis Splendor X
Manufacturer	Candela	Lumenis
Built by (OEM)	Candela Corporation	Lumenis Be Ltd.
Category	Dual-wavelength platform	Dual-wavelength laser
Technology	755nm alex + 1064nm Nd:YAG (Nd:YAG)	755+1064nm BLEND X square spot
Launch year	2013	2018
Status	Discontinued	Current
OEM platform	—	—

Manufacturer

Candela GentleMax Pro: Candela
Lumenis Splendor X: Lumenis

Built by (OEM)

Candela GentleMax Pro: Candela Corporation
Lumenis Splendor X: Lumenis Be Ltd.

Alternatives

Other devices in the same subcategory.

Cutera Excel HR

Dual-wavelength laser

New: $95k–$135k

Lutronic Clarity II

Dual-wavelength laser

New: $100k–$140k

Quanta System Thunder (MT)

Dual-wavelength laser

New: $110k–$150k

Quanta System Duetto MT / MT Evo

Dual-wavelength laser

New: $80k–$120k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Prices are researched estimates, not quotes. Not medical, legal or regulatory advice.